Advanced breast cancer: a phase II trial with gemcitabine.

Keywords

Medicine, Gemcitabine, Oncology, Internal medicine, Cancer

References

• Action of 2',2'-difluorodeoxycytidine on DNA synthesis.Peng Huang, Sherri Chubb, Larry W. Hertel — 1991
• Modulation of deoxycytidylate deaminase in intact human leukemia cells. Action of 2',2'-difluorodeoxycytidine.Xu Yi-Zheng, William Plunkett — 1992
• Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy.P. Fumoleau, F.M. Delgado, T. Delozier — 1993
• Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study.Raymond P. Abratt, W. R. Bezwoda, Geoffrey Falkson — 1994
• Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study.Heather Anderson, Birthe Lund, Flemming W. Bach — 1994
• Carboplatin in the treatment of advanced breast cancer: a phase II study using a pharmacokinetically guided dose schedule.Mary O’Brien, Denis Talbot, Ian E. Smith — 1993
• A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.James L. Abbruzzese, Ralf Grunewald, Elizabeth A. Weeks — 1991
• Phase I clinical trial of gemcitabine given as an intravenous bolus on 5 consecutive days.Timothy J. O’Rourke, T.D. Brown, Kathleen A. Havlin — 1994
• Effective palliation of advanced breast cancer with weekly low dose epirubicin.William G. Jones — 1989
• High-dose etoposide in treatment of metastatic breast cancer.W.R. Bezwoda, Lesley Seymour, Samuel Ariad — 1992
• Randomized Trial of Two Doses of Taxol in Metastatic Breast Cancer: An Interim AnalysisU. Klaassen, K. Diergarten, H Dittrich — 1994
• 2′,2′-Difluorodeoxycytidine Metabolism and Mechanism of Action In Human Leukemia CellsWilliam Plunkett, Varsha Gandi, Sherri Chubb — 1989
• Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine).Larry W. Hertel, G B Boder, Julian S. Kroin — 1990
• Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer (SCLC). A study of the National Cancer Institute of Canada Clinical Trials Group.Yvon Cormier, E. Eisenhauer, A. Muldal — 1994
• Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) in previously treated ovarian cancer patients.Birthe Lund, Ole Hansen, Karen Theilade — 1994
• Phase II study of edatrexate in chemotherapy-naive patients with metastatic breast cancer.Jan H. Schornagel, S. van der Vegt, Jaap Verweij — 1992
• Doxorubicin versus mitomycin versus doxorubicin plus mitomycin in advanced breast cancer: a randomized study.Magnus Andersson, Søren Daugaard, Hans von der Maase — 1986
• Randomized phase II study of single-agent epirubicin +/− verapamil in patients with advanced metastatic breast cancerK. Mross, C. Bohn, L. Edler — 1993
• Gemcitabine: current status of phase I and II trials.S. Kaye — 1994

Cited by

• Leucovorin, 5-fluorouracil, and gemcitabine: A phase I studyElizabeth Poplin, John D. Roberts, M. P. Tombs — 2004
• Radiologist review versus group peer review of claimed responses in a phase II study on high-dose ifosfamide in advanced soft tissue sarcomas of the adult: a study of the EORTC Soft Tissue and Bone Sarcoma GroupVanessa Bonet Amela, Vicent Pallarés Pascual — 2000
• Treatment for anthracycline-pretreated metastatic breast cancer.Ramle Muhammad Muslim — 2002
• Gemcitabine: monochemotherapy of breast cancer.C. C. Kircher, J. J. Margitan, Stanley P. Sander — 2006
• Long Non-Coding RNAs as New Master Regulators of Resistance to Systemic Treatments in Breast CancerAnna Keefe, Vanessa Tantillo, Dennis K. Norman — 2018
• Gemcitabine plus cisplatin in breast cancer.Robert Alan Nagourney — 2001
• Gemcitabine plus dose-escalated epirubicin in advanced breast cancer: results of a phase I studyDiana Lüftner, Bernd Flath, C. Akrivakis — 2004
• The Evaluation of Gemcitabine in Resistant or Relapsing Multiple Myeloma, Phase II: a Southwest Oncology Group StudyJames K. Weick, John J. Crowley, Mohamed Hussein — 2002
• Achievement of Complete Remission in Refractory Hodgkin's Disease with Prolonged Infusion of GemcitabineOrhan Sezer, Jan Eucker, Christian Jakob — 2004
• Clinical Pharmacokinetics of Nucleoside AnaloguesStephen A. Johnson — 2000
• Gemcitabine in combination with trastuzumab and/or platinum salts in breast cancer cells with HER2 overexpression.Gottfried E. Konecny, Mark D. Pegram — 2004
• Recent advances in the systemic therapy of breast cancer.John T. Cole — 2000
• Pyrimidine and Purine AntimetabolitesGiuseppe Pizzorno, Robert B. Diasio, Yung-Chi Cheng — 2003
• Treatment of advanced breast cancer with gemcitabine and vinorelbine.Gabriel N. Hortobágyi — 2001
• A phase I study of gemcitabine, 5-fluorouracil and leucovorin in patients with advanced, recurrent, and/or metastatic solid tumorsJordan Berlin, Dona Alberti, Rhoda Arzoomanian — 1998
• Evaluation of Gemcitabine in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Southwest Oncology Group Phase II StudyWolfram E. Samlowski, Holly Gundacker, J. Philip Kuebler — 2004
• Near-infrared fluorescence heptamethine carbocyanine dyes mediate imaging and targeted drug delivery for human brain tumorBoyang Jason Wu, Changhong Shi, Gina Chia‐Yi Chu — 2015
• New treatment modalities and pharmacologic refinements for metatstatic breast cancerCarolien H. Smorenburg — 2002
• Gemcitabine, paclitaxel, and trastuzumab in metastatic breast cancer.George W Sledge — 2001
• Respuesta terapéutica a gemcitabina en cáncer de mama avanzado en relación con factores immunohistoquímicosRaquel Gerson, Alberto Serrano, Alberto Villalobos — 2002

Related papers

• A Comparison of Gemcitabine in Two Doses for Stage III or IV Non-small Cell Lung Cancer: a Multi-Institutional Phase II StudyHee Sun Park, Jin An, Yeun Seun Lee — 2007
• Comparison of Gemcitabine monotherapy with Gemcitabine and Cisplatin combination in metastatic pancreatic cancer: a retrospective analysis.Yakup Ergün, Nuriye Özdemir, Ebru KARCI GÜNER — 2018
• EFFORTS TO IMPROVE THE ANTI-TUMOR EFFECT OF GEMCITABINE IN HUMAN PANCREATIC CANCERShoji Nakamori, Masaki Kashiwazaki, Masakazu Ikenaga — 2007
• A randomized controlled trial of gemcitabine plus cisplatin versus gemcitabine alone in the treatment of metastatic pancreatic cancerYee Chao, Chen-Yi Wu, Jack Wang — 2013
• Initial comparative study on the efficacy of single agent gemcitabine versus combination gemcitabine and cisplatin in Filipino patients with advanced non-small cell lung cancerA Gorospe, Gloria Cristal‐Luna, R. Li — 2000
• High peroxidasin-like expression is a potential and independent prognostic biomarker in breast cancerYanqing Li, Yan Jiao, Zhangping Luo — 2019
• Subtype-specific associations between breast cancer risk polymorphisms and the survival of early-stage breast cancerFangmeng Fu, Wenhui Guo, Yuxiang Lin — 2018
• Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving TherapyCindy Matsen — 2016